Publications

1. Hamaguchi M, Meth, JL, Kanis MJ, Von Klitzing C, Wei W, Esposito D, Rodgers L, Walsh T, Welsh P, King MC and Wigler MH. DBC2, a candidate for a tumor suppressor gene involved in breast cancer (Bases 1-2508). Proc. Natl. Acad. Sci. U.S.A. 99 (21), 13647-13652 (2002) http://www.ncbi.nlm.nih.gov/nuccore/AF420001.1

2. Kanis MJ, Kesterson J, and Lele S. The use of cod liver oil by patients receiving pegylated liposomal doxorubicin is associated with a lack of palmar plantar erythrodysesthesia. Eur J Gynaecol Oncol, 2009, 30(4), 387-388.

3. Kanis M, Kesteron J, Shroff S, Lele S, Mhawech-Fauceglia P. Malignant mixed müllerian tumor of primary peritoneal origin: A report of two cases. Ann Diagn Pathol, 2010, 15(4):273-277.

4. Kiran G, Kesterson J, Orzerkan K, Kanis M., Lele, S. Evaluation of the outcome benefit conferred by intensive surveillance strategies in women with early stage endometrial cancer.  Eur J Gynaecol Oncol. 2013; 34(6):522-6.

5. Kanis M, Momeni M, Prasad-Hayes M, Zakashanksy K, Chuang L.  5-mm balloon trocar herniation: A review of two cases. J Minim Invasive Gynecol. 2013 Sep-Oct; 20(5):723-6.

6. Kanis M, Momeni M, Zakashansky K.  A case report: pilonidal cyst of the clitoris. Female Pelvic Med Reconstr Surg. 2014 Sep-Oct; 20(5):297-8.

7. Chuang L … Kanis M. Teaching gynecologic oncology in low resource settings: A collaboration of health volunteers overseas and the Society of Gynecologic Oncology. Gynecol Oncol. 2014 Dec; 135(3): 580-2.

8. Kanis M, Kolev V, Getrajdman J, Zakashansky K, Chuang L, Rahaman J. Carcinosarcoma of the ovary: A single institution experience. Eur J Gynaecol Oncol. 2016; 37(1):75-9.

9. Kanis M, Getrajdman J, Rahaman J, Zakashansky K, Chuang L, Kolev V. Detection and correlation in pre-operative, frozen and final pathology in high-risk histology endometrial cancer. Eur J Gynaecol Oncol. 2016; 37(3):338-41.

10. Chuang L, Kanis M, et al. Treating locally advanced cervical cancer with concurrent chemoradiation without brachytherapy in low resource countries. Am J of Clin Oncol. 2016; 29(1):92-7.

11. Kanis M, Lurain J. Pulmonary resection in the treatment of high-risk gestational trophoblastic neoplasia. Int J of Gynecol Cancer, 2016; 26(4):796-800.

12. Rydzewski N, Strohl A, Donnelly E, Kanis M, Lurain J, Nieves-Niera W, Strauss J. Receipt of vaginal brachytherapy is associated with improved survival in women with stage I endometrioid adenocarcinoma of the uterus: a National Cancer Database Study. Cancer. 2016; 122(23) 3724-31.

13. Seagle B, Kanis M, Strohl A, Shahabi S. Survival of women with mullerian adenosarcoma: a National Cancer Database Study. Gynecol Oncol, 2016 (143:3)636-641.

14. Cheng A, Li M, Kanis M, et al. Is it Necessary to Perform Routine Appendectomy for Mucinous Ovarian Neoplasms? A Retrospective Study and Meta-Analysis. Gynecol Oncol, 2017 (144:1)215-222.

15. Seagle B, Kanis M, Shahabi S, Strauss J. Stage I uterine carcinosarcoma: Matched cohort analyses for lymphadenectomy, chemotherapy, and brachytherapy. Gynecol Oncol, 2017 (145:1) 71-77.

16. Zhang Q, Li W, Kanis M, et al. Oncologic and obstetrical outcomes with fertility-sparing treatment of cervical cancer: a systematic review and meta-analysis. Oncotarget, 2017; 8(28) 580-592.

17. Zhang Q, Qi G, Kanis M, et al. Comparison among fertility-sparing therapies for well differentiated early-stage endometrial carcinoma and complex atypical hyperplasia. Oncotarget, 2017; 8(34) 642-653.

18. Kanis M, Zielenbach M, Blanco L, Kamali R, Horowitz J, Lurain J. Painless vulvar masses as initial manifestation of marginal zone lymphoma. J Lower Genital Tract Disease, 2018; 22(1) 82-84.

19. Zhang Q, Kanis M, Ubago J, Liu D, Scholtens D, Strohl A, Lurain J, Shahabi S, Kong B, Wei J. The selected biomarker analysis in five types of uterine smooth muscle tumors. Hum Path, 2018; 76:17-27.

20. Rydzewski N, Kanis M, Donnelly E, Lurain J, Strauss J. Role of Adjuvant External Beam Radiotherapy and Chemotherapy in One Versus Two or More Node-Positive Vulvar Cancer: A National Cancer Database Study. Radiother and Oncol, 2018; (18)30167-1.

21. Kanis M, Rausch J, Greendyk R, Dayno M, Lurain J. Use of granulocyte colony stimulating factors (G-CSFs) with multiagent chemotherapy for gestational trophoblastic neoplasia (GTN). J of Reprod Med, May-June 2018, 209-212.

22. Kanis M, Qiang W, Pineda M, Maniar K, Kim J. A small molecule inhibitor of the perinucleolar compartment, ML246, attenuates growth and spread of ovarian cancer. Gynecol Oncol Res Pract, 2018; 5:7.

23. Sheu J, Palileo A, Chen M, Hoepner L, Abulafia O, Kanis M, Lee Y. Hospice utilization in advanced cervical malignancies: An analysis of the National Inpatient Sample. Gynecol Oncol, April 2019.

24. Mei S, Gibbs J, Lee Y, Kanis M. Clinical comparison between neuroendocrine and endometrioid type carcinoma of the uterine corpus. J Gynecol Oncol, January 2019; 30(4):e58.

25. Salman B, Momeni-Boroujeni A, Lee Y, Kanis M. Cervical rhabdomyosarcoma in an endocervical polyp of a 50 year old patient with intermenstrual bleeding. Gynecologic Oncology Reports, January 2019; 28:6-8.

26. Gibbs J, Mei S, Economos K, Lee Y, Kanis M. Clinicopathologic features, incidence, and survival trends of gynecologic neuroendocrine tumors: a SEER database analysis. Am J Obstet Gynecol 2019; 221(1):53.e1-53.e6.

27. McEachron J, Mendoza R, Lee Y, Kanis M. Breast metastases: A rare manifestation of uterine serous carcinoma. Gynecologic Oncology Reports, 2019; 30:100500.

28. McEachron J, Kanis M. A Clinicopathologic Study of Endometrial Cancer Metastatic to Bone: Identification of Microsatellite Instability Improves Treatment Strategies. Gynecologic Oncology Reports, Feb 2020.

29. McEachron J, Sabir S, Bennett M, Marshall L, Lee Y, Kanis M. Noninvasive Negative Pressure Wound Therapy Decreases Postoperative Complications in Patients Undergoing Laparotomy for Benign Gynecologic Indications and Gynecologic Malignancy. Int J of Gynecol Cancer, March 2020.

30. McEachron J, Hastings V, Malakhov N, Gorelick C, Economos K, Lee Y, Kanis M. Clinically significant discrepancy between clinical and pathologic stage of early operable cervical cancer. J Clinical Oncology and Research, April 2020.

31. Hastings V, McEachron J, Kanis M. Cutaneous metastasis of PD-L1 positive ovarian cancer. Gynecologic Oncology Reports , June 2020.

Abstracts/Posters

1. Kesterson J, Kanis M, Lele S.  The role of screening for recurrent cervical cancer. Society of Gynecologic Oncologists 41st Annual Meeting on Women’s Cancer, San Francisco, CA, March 2010.

2. Kanis M, Momeni M, Prasad-Hayes M, Zakashanksy K, Chuang L.  5-mm balloon trocar herniation: A review of two cases. Icahn School of Medicine at Mount Sinai Annual Resident and Fellow Research Day. NY, NY, June 2013.

3. Kanis M, Kolev V, Getrajdman J, Zakashansky K, Chuang L, Rahaman J. Carcinosarcoma (CS) of the ovary: A single institution experience. American Society of Clinical Oncology Annual Meeting, Chicago, IL, June 2014.

4. Kanis M, Qiang W, Lurain R, Huang S, Kim J. Efficacy of metarrestin against ovarian cancer. Center for Reproductive Science Minisymposium. Chicago, IL, January 2015.

5. Kanis M, Lurain J. Pulmonary resection in the treatment of high-risk gestational trophoblastic neoplasia. Featured Poster at the Society for Gynecologic Oncologists 46th Annual Meeting on Women’s Cancer, Chicago, IL, March 2015.

6. Kanis M, Qiang W, Lurain R, Huang S, Kim J. Metarrestin: A novel compound active in ovarian cancer. Lewis Landsberg Research Day, Northwestern University, Chicago, IL, April 2015.

7. Kanis M, Qiang W, Lurain R, Huang S, Kim J. Efficacy of metarrestin against ovarian cancer. American Society of Clinical Oncology (ASCO) Annual Meeting, Chicago, IL, June 2015.

8. Farag S, Andikyan V, Fields J, Kanis M, Rahaman J, Hayes M. Clinical outcomes of type II endometrial cancer in open versus minimally invasive staging surgery. American Association of Gynecologic Laparoscopists Global Congress, Las Vegas, NV, November 2015.

9. Kanis M, Hope K, Seagle B, Shahabi S, Shulman L. Ovarian Cancer Early Detection & Prevention Program (OCEDPP): A Specimen and Data Study. Featured Poster at the Society for Gynecologic Oncologists 47th Annual Meeting on Women’s Cancer, San Diego, CA, March 2016.

10. Kanis M, Bender J, Strohl A, Scholtens D, Liu D, Lurain J, Shahabi S, Wei J. Associations of clinical, molecular and immunohistochemical parameters in five different types of uterine smooth muscle tumors. American Association of Cancer Research, New Orleans, LA, April 2016.

11. Strohl A, Rydzewski N, Donnelly E, Kanis M, Shahabi S, Strauss J. Adjuvant Chemotherapy and Radiation is Associated with Improved Survival in Women with Node-Positive Endometrial Cancer: A National Cancer Data Base Study. ASCO Annual Meeting, Chicago, IL, June 2016.

12. Rydzewski N, Strohl A, Donnelly E, Kanis M, Lurain J, Nieves-Niera W, Strauss J. Receipt of Adjvuant Radiotherapy is Associated with Improved Survival in Women with Stage I Endometrioid Adenocarcinoma of the Uterus: a National Cancer Database Study. ASCO Annual Meeting, Chicago, IL, June 2016.

13. Kanis M, Rausch J, Greendyk R, Dayno M, Lurain J. Use of granulocyte colony stimulating factors (G-CSFs) with multiagent chemotherapy for gestational trophoblastic neoplasia (GTN).  Society for Gynecologic Oncologists 48th Annual Meeting on Women’s Cancer, National Harbor, MD, March 2017.

14. Kanis M, Seagle B, Shahabi S, Strauss J. Vaginal brachytherapy and multiagent chemotherapy increases survival of women with stage I uterine carcinosarcoma: A National Cancer Data Base Study. Featured poster at the Society for Gynecologic Oncologists 48th Annual Meeting on Women’s Cancer, National Harbor, MD, March 2017.

15. Alvi F, Strohl A, Kanis M, Shahabi S. The influence of political party on gynecologic cancer research funding in the United States. Featured poster at the Society for Gynecologic Oncologists 48th Annual Meeting on Women’s Cancer, National Harbor, MD, March 2017.

16. Kanis M, Merrill D, Swetzig W, Cardenas H, Kim J, Matei D, Turek J, Nolte D. A pilot study evaluating biodynamic imaging (BDI) as a novel method in predicting response to chemotherapy in ovarian cancer. Society for Gynecologic Oncologists 48th Annual Meeting on Women’s Cancer, National Harbor, MD, March 2017.

17. Kanis M, Rydzewski N, Donnelly E, Lurain J, Strauss J. Role of radiation therapy in vulvar cancer with one or more than one positive lymph node. European Society for Radiation Oncology Annual Meeting, Vienna, Austria, May 2017.

18. Testani E, Chen M, Lee R, Palileo A, Abulafia O, Kanis M and Lee Y. Molecular profiling of endometrial carcinomas in a Caribbean black population. SGO 2018 Annual Winter Meeting, Snowmass, Colorado, February 2018.

19. Mei S, Kanis M, Gorelick C, Abulafia O, Lee Y. A comparison between vulvar melanoma and vulvar squamous cell carcinoma, and other mucocutaneous melanomas with a focus on racial disparities. Society for Gynecologic Oncologists 49th Annual Meeting on Women’s Cancer, New Orleans, LA, March 2018.

20. Sheu J, Palileo A, Salman B, Kanis M, Lee Y. Perioperative complications in elderly patients undergoing hysterectomy for gynecologic malignancies. Society for Gynecologic Oncologists 49th Annual Meeting on Women’s Cancer, New Orleans, LA, March 2018.

21. Sheu J, Palileo A, Hoepner L, Kanis M, Lee Y. Hospice utilization in advanced cervical malignancies: An analysis of the National Inpatient Sample. Society for Gynecologic Oncologists 49th Annual Meeting on Women’s Cancer, New Orleans, LA, March 2018.

22. Mei S, Kanis M, Lee Y, Abulafia O, Economos K. Clinical comparison between neuroendocrine tumor and endometrioid type carcinoma of the uterine corpus. 17th Annual International Gynecologic Cancer Society Meeting, Kyoto, Japan, September 2018.

23. Mei S, Lee Y, Kanis M. Epidemiology and clinical trends of gynecological neuroendocrine tumors in the US. 17th Annual International Gynecologic Cancer Society Meeting, Kyoto, Japan, September 2018.

24. Palileo A, Chen Y, Lee Y, Kanis M. Clinicopathologic Features of Adult Gynecologic Rhabdomyosarcoma: An Analysis of the USA SEER Database. 17th Annual International Gynecologic Cancer Society Meeting, Kyoto, Japan, September 2018.

25. Mendoza R… Kanis M… Lee Y. Expression pattern and clinical significance of PD-1 and PD-L1 in squamous cell carcinoma of the cervix. Annual Mid-Atlantic Gynecologic Oncology Society Meeting, Columbus, Ohio, October 2018.

 26. Gibbs J…Kanis M. Clinically significant discrepancy between clinical and pathologic stage of early-operable cervical cancer. ASCO Annual Meeting June 2019, Chicago, IL.

 Presentations

1.  Kesterson J, Kiran G, Ozerkan K, Kanis M, Groman A, Lele S.  Evaluation of the Outcome Benefit Conferred by Intensive Surveillance Strategies in Women with Early Stage Endometrial Cancer. Plenary Presentation at Society for Gynecologic Oncologists 42nd Annual Meeting on Women’s Cancer. Orlando, Florida, March 2011.

2. Kanis M, Qiang W, Lurain R, Huang S, Kim J. Metarrestin: A Novel Compound Active in Ovarian Cancer. Western Association of Gynecologic Oncologists, Santa Rosa, CA, June 2015.

3. Kanis M, Lurain J. Pulmonary Resection in the Treatment of High-Risk Gestational Trophoblastic Neoplasia. XVIII World Congress on Gestational Trophoblastic Diseases, Bali, Indonesia, September 2015.

4. Kanis M. Gestational Trophoblastic Disease and Vulvar Cancer. The 20th Annual Comprehensive Obstetrics and Gynecology Review Course, SUNY Downstate, Brooklyn, NY, June 2018.

5. Sabir S, Bennett M, Marshall L, Lee Y, Kanis M. Noninvasive Negative Pressure Wound Therapy Decreases Postoperative Complication Rates and Hospital Stays in Gynecologic Oncology Patients. Western Association of Gynecologic Oncologists, Park City, Utah, June 2018.

6. Castillo D…Kanis M, Lee Y. Does Obesity Impact Adequate Cervical Cancer Screening? Annual Mid-Atlantic Gynecologic Oncology Society Meeting, Columbus, Ohio, October 2018.

7. McEachron J, Heyman T, Shanahan L, Friedman M, Economos K, Gorelick C, Singhal P, Lee YC, Kanis MJ. Multimodality adjuvant therapy associated with improved survival in uterine carcinosarcoma. Society of Gynecologic Oncology, Annual Winter Meeting; Aspen, CO. February 2020.